Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

US Patent 10179912 · Granted Jan 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antisense oligonucleotides for dystrophin exon skipping2025
Oligonucleotide comprising an inosine for treating DMD2023
Substances for targeting various selected organs or tissues2022
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrop2022
RNA modulating oligonucleotides with improved characteristics for the treatment 2022
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2021
Oligonucleotide comprising an inosine for treating DMD2021
Means and methods for counteracting muscle disorders2021
RNA modulating oligonucleotides with improved characteristics for the treatment 2021
RNA modulating oligonucleotides with improved characteristics for the treatment 2021
Methods and means for efficient skipping of at least one of the following exons 2020
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2020